Explore

Trendline Trendline
Gilead Sciences Acquires Tubulis for $5 Billion to Enhance Cancer Treatment Capabilities

Gilead Sciences Acquires Tubulis for $5 Billion to Enhance Cancer Treatment Capabilities

Gilead Sciences Acquires Tubulis for $5 Billion to Enhance Cancer Treatment Capabilities
Trendline Trendline
Agilitas Sells Integris Composites to Triton Partners Amid Global Expansion

Agilitas Sells Integris Composites to Triton Partners Amid Global Expansion

Agilitas Sells Integris Composites to Triton Partners Amid Global Expansion
Trendline Trendline
KPMG Report Predicts 2026 Surge in Mergers and Acquisitions Driven by Carve-Outs

KPMG Report Predicts 2026 Surge in Mergers and Acquisitions Driven by Carve-Outs

KPMG Report Predicts 2026 Surge in Mergers and Acquisitions Driven by Carve-Outs
Trendline Trendline
Pershing Square Offers $64 Billion for Universal Music Group, Aiming for U.S. Relisting

Pershing Square Offers $64 Billion for Universal Music Group, Aiming for U.S. Relisting

Pershing Square Offers $64 Billion for Universal Music Group, Aiming for U.S. Relisting
Trendline Trendline
Merck Adjusts Acquisition Offer for Terns Pharmaceuticals After Leukemia Data Update

Merck Adjusts Acquisition Offer for Terns Pharmaceuticals After Leukemia Data Update

Merck Adjusts Acquisition Offer for Terns Pharmaceuticals After Leukemia Data Update
Trendline Trendline
Gilead Sciences Expands Oncology Portfolio with $5 Billion Tubulis Acquisition

Gilead Sciences Expands Oncology Portfolio with $5 Billion Tubulis Acquisition

Gilead Sciences Expands Oncology Portfolio with $5 Billion Tubulis Acquisition
Trendline Trendline
Tinicum and Blackstone Acquire UK’s Senior in $1.9 Billion Deal

Tinicum and Blackstone Acquire UK’s Senior in $1.9 Billion Deal

Tinicum and Blackstone Acquire UK’s Senior in $1.9 Billion Deal
Trendline Trendline
Universal Music Group Receives $64.4 Billion Takeover Bid from Pershing Square

Universal Music Group Receives $64.4 Billion Takeover Bid from Pershing Square

Universal Music Group Receives $64.4 Billion Takeover Bid from Pershing Square
Trendline Trendline
Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9 Billion, Expanding Treatment Options for Prader-Willi Syndrome

Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9 Billion, Expanding Treatment Options for Prader-Willi Syndrome

Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9 Billion, Expanding Treatment Options for Prader-Willi Syndrome
Trendline Trendline
Bed Bath Beyond Acquires The Container Store in $150 Million Deal to Expand Retail Presence

Bed Bath Beyond Acquires The Container Store in $150 Million Deal to Expand Retail Presence

Bed Bath Beyond Acquires The Container Store in $150 Million Deal to Expand Retail Presence
Trendline Trendline
Pershing Square Makes $64 Billion Bid for Universal Music Group

Pershing Square Makes $64 Billion Bid for Universal Music Group

Pershing Square Makes $64 Billion Bid for Universal Music Group
Trendline Trendline
Universal Music Group Faces $64 Billion Takeover Bid from Pershing Square

Universal Music Group Faces $64 Billion Takeover Bid from Pershing Square

Universal Music Group Faces $64 Billion Takeover Bid from Pershing Square